Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Guiyun Wu, MD, is currently a staff physician at the Cleveland Clinic, Department of Radiology, Molecular and Functional Imaging. He is specialized in Nuclear Imaging, especially functional imaging of the brain.
He received his medical education in Inner Mongolian Medical College and additional research training in Chinese Academy of Medical Science in China. He had several years of research experience in molecular and cellular biology before his clinical training. He completed his residency training in neurology at University of Pittsburgh Medical Center and fellowship training in Nuclear Medicine and Movement Disorder at the University of Michigan Medical Center before he joined the Cleveland Clinic.
He is board-certified by American Board of Nuclear Medicine and American board of Psychiatry and Neurology. He served as an active member of several professional medical societies: American Society of Nuclear Medicine, American Academy of Neurology, Radiology Society of North America, and European Society of Nuclear Medicine. He is interested in functional imaging of brain and actively participated in several company and institution sponsored research projects with a wide range of publications.
PET and SPECT imaging in the seizure localization of epilepsy surgery, early diagnosis of dementia like Alzheimer's and frontotemporal dementia, cerebral vascular diseases, psychiatric disorders, brain and neuroendocrine tumor, new tracer development for functional neuroimaging, new applications of PET-CT and SPECT-CT imaging in oncology imaging
Awards & Honors
Merk Young Investigator Award
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 8/27/2013, Dr. Wu has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.